Press Ganey consumer experience report reveals key insights on safety, social capital, and consumerism shaping healthcare decisions in 2023 and beyond.

According to the Adhishthana framework, stocks typically form a Cakra structure between Phases 4 and 8, a channel-like setup with an arc that generally carries bullish implications. A clean breakout ...

(Reuters) -U.S. Secretary of State Marco Rubio discussed avenues for expanding U.S. participation in Liberia's critical minerals sector in a meeting this week with Liberian Foreign Minister Sara ...

A recent report shows that the Georgia agency responsible for Medicaid has failed to adopt or follow most prior audit recommendations intended to improve dental care access for children, including ...

Bayer has selected Interpublic to handle global media, creative and production services for its consumer health division after a formal review, the companies have confirmed. Bayer made a point of ...

News outlets across the country like Time magazine, the Wall Street Journal and the Minnesota Star Tribune have picked up on a trend: Mothers of young children are leaving the labor force (front page, ...

CNBC's Elaine Yu explores China's silver economy and consumer health care sector, and how one company is seeing opportunities in the space. Donald Trump health update issued after physical 'Keep your ...

DALLAS--(BUSINESS WIRE)--Enhabit, Inc. (NYSE: EHAB), a leading national home health and hospice provider, today announced its participation in the Jefferies 2025 Healthcare Services Conference.

SAN FRANCISCO--(BUSINESS WIRE)-- Levi Strauss & Co. (LEVI) today announced that Harmit Singh, chief financial and growth officer, will participate in a fireside chat at the Wells Fargo 8th Annual ...

Correction, Sept. 9: The list price of Zepbound has been revised from an earlier version of this article. Eli Lilly’s decision to sell its obesity drug Zepbound directly to patients for $499 per month ...

Prestige Consumer Healthcare's roll-up strategy built a diverse brand portfolio, but revenue growth has now stagnated. At 14.8x forward earnings, PBH's valuation isn't compelling in today's market, ...